Skip to main content
Signal8

Arcturus Therapeutics Holdings Inc. (ARCT)

Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by specific CFTR gene mutations. The company also advances vaccine initiatives such as LUNAR-COV19 and LUNAR-FLU. Arcturus has cultivated a range of strategic collaborations, including partnerships with Vinbiocare Biotechnology Joint Stock Company for manufacturing COVID-19 vaccines; Janssen Pharmaceuticals, Inc., to create nucleic acid-based therapies for hepatitis B virus; Ultragenyx Pharmaceutical, Inc., for developing mRNA therapeutics aimed at rare disease targets; CureVac AG, to progress mRNA therapeutic and vaccine candidates across various indications; the Singapore Economic Development Board and Duke-NUS Medical School, specifically for the LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc., focused on discovering siRNA medicines for non-alcoholic steatohepatitis (NASH). Founded in 2013, Arcturus Therapeutics maintains its corporate headquarters in San Diego, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCTHealthcare
-9.22%$11.03
AH$10.51-4.67%vs close
Mkt Cap$313.51M
Float28.42M
O/S28.42M
Vol
$ Vol
RVOL
Inst Own86.8%
SI19.2%
Earnings
Dilution
Financials Summary
Revenue$67.22M
Net Income-$65.78M
Total Assets$271.15M
Free Cash Flow-$74.27M
Debt & Equity
Debt 10%
Equity 90%
Total Debt$25M
Total Equity$213.99M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in ARCT's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$271.15M
Liabilities$57.16M
Accounts Receivable$5.56M
Accounts Payable$4.24M
Inventory$0
PP&E (Net)$27.82M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue$67.22M$138.39M$157.75M$205.75M$12.36M$9.54M$20.79M$15.75M$13M$20.38M$6.14M$0$0$0$0
YoY Growth-51.4%-12.3%-23.3%1564.8%29.6%-54.1%32.0%21.2%-36.2%232.1%-----
Cost of Revenue$3.02M$0$0$0$0$55.95M$0$16.98M$410K$294K$51K$0$0$0$0
Gross Profit$64.2M$138.39M$157.75M$205.75M$12.36M-$46.41M$20.79M-$1.23M$12.59M$20.09M$6.09M$0$0$0$0
Gross Margin95.5%100.0%100.0%100.0%100.0%-486.5%100.0%-7.8%96.8%98.6%99.2%----
Research and Development$112.21M$195.16M$192.13M$147.75M$173.76M$57.85M$33.64M$16.98M$15.92M$18.39M$13.46M$25.11M$7.07M$818K$1.82M
Selling, General, and Administrative$46.08M$52.82M$52.87M$46.07M$41.45M$25.12M$12.66M$20.58M$7.57M$5.36M$4.99M$5.84M$3.22M$683K$2.08M
Other-$19.14M-$13.92M-$9.05M-$244K$0-$57.85M$0$0-$348K$1.42M$1.25M$2.13M$0$0$0
Total Operating Expenses$139.15M$234.06M$235.95M$193.58M$215.21M$25.12M$46.3M$37.56M$23.49M$25.17M$19.7M$33.08M$10.29M$1.5M$3.91M
Operating Income (EBIT)-$74.95M-$95.67M-$78.2M$12.18M-$202.85M-$71.52M-$25.51M-$21.81M-$10.49M-$25.17M-$19.7M-$33.08M-$10.29M-$1.5M-$3.91M
Operating Margin-111.5%-69.1%-49.6%5.9%-1641.3%-749.8%-122.7%-138.5%-80.7%-123.5%-320.9%----
Interest Expense$0$0$767K$3M$2.67M$831K$854K$186K$150K$295K$251K$2K$197K$80K$44K
Interest Income$10.1M$15.2M$17.36M$2.58M$753K$470K$408K$514K$89K$9K$1K$239K$22K$2K$21K
Other Income (Expense)$9.17M$14.72M$50.31M-$1.53M-$822K-$624K-$478K$26K-$409K-$536K$11K$227K-$197K-$78K-$23K
Income Before Tax (EBT)-$65.78M-$80.94M-$27.89M$10.64M-$203.67M-$72.15M-$25.99M-$21.79M-$10.9M-$24.53M-$19.4M-$32.85M-$10.49M-$1.58M-$3.93M
Income Tax Expense$0-$4K$1.83M$1.29M$0$0$0$212K$1K$73K$51K-$17K$61K$0$21K
Net Income-$65.78M-$80.94M-$29.73M$9.35M-$203.67M-$72.15M-$25.99M-$21.79M-$10.9M-$24.6M-$19.45M-$32.83M-$10.55M-$1.58M-$3.93M
Net Income Margin-97.9%-58.5%-18.8%4.5%-1648.0%-756.3%-125.0%-138.3%-83.9%-120.7%-316.9%----
Supplementary Data
EPS-2.40-3.00-1.120.35-7.74-3.55-2.13-2.16-3.53-6.25-6.29-16.81-7.25-0.99-2.47
Diluted EPS-2.40-3.00-1.120.35-7.74-3.55-2.13-2.16-3.53-6.25-6.29-16.81-7.25-0.99-2.47
Weighted Average OS27.39M27.00M26.63M26.45M26.32M20.30M12.07M10.07M3.09M3.94M3.09M1.95M1.45M1.59M1.59M
EBITDA-$62.76M-$77.4M-$24.16M$15.17M-$199.81M-$70.64M-$24.45M-$20.71M-$10.34M-$947K-$1.72M-$32.81M-$10.28M-$1.51M-$3.92M
EBITDA Margin-93.4%-55.9%-15.3%7.4%-1616.7%-740.6%-117.6%-131.5%-79.6%-4.6%-28.0%----
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$230.91M$237.03M$292M$391.88M$370.49M$462.89M$71.35M$36.71M$24.96M$2.3M$16.66M$2.18M$22.09M$97K$55K
Short-Term Investments$0$0$0$0$0$0$0$0$23.61M$47.94M$34.02M$19.52M$28.01M$0$517K
Cash and Short-Term Investments$230.91M$237.03M$292M$391.88M$370.49M$462.89M$71.35M$36.71M$48.57M$50.24M$50.68M$21.7M$50.1M$97K$572K
Accounts Receivable$5.56M$3.97M$32.06M$2.76M$3.37M$2.13M$2.18M$4.48M$480K$3.63M$328K$117K$46K$10K$93K
Inventory$0$0$0$0$0$0$0$0$1.46M-$521K-$116K$0-$46K$0$0
Other Current Assets$4.97M$64.98M$55M$8.69M$0$0$0$0$756K$111K$93K$0$0$7K$0
Total Current Assets$241.45M$305.98M$386.59M$403.33M$378.96M$467.79M$74.29M$41.83M$50.87M$51.3M$52.35M$22.13M$50.22M$180K$667K
Long-Term Assets
Property, Plant & Equipment Net$27.82M$36.2M$40.93M$44.96M$11.26M$8.56M$7.48M$1.98M$1.05M$240K$227K$97K$49K$18K$25K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$1.89M$0$1.89M$0$515K$0$263K$288K$107K$0$19M$0$0$3K$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$26.61M$0$0$0$0$0$0
Other Long-Term Assets$0$1.89M$0$2.09M$2.08M$107K$107K$107K$107K$29K$110K$95K$57K$0$512K
Total Long-Term Assets$29.7M$38.09M$42.81M$47.05M$13.85M$8.67M$7.85M$2.37M$1.16M$269K$19.34M$192K$106K$21K$537K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$271.15M$344.07M$429.4M$450.39M$392.81M$476.46M$82.14M$44.2M$52.02M$51.57M$71.68M$22.32M$50.32M$201K$1.2M
Liabilities
Current Liabilities
Accounts Payable$4.24M$7.19M$5.28M$7.45M$10.06M$10.77M$5.79M$2.4M$1.79M$3.36M$57K$305K$47K$23K$124K
Short-Term Debt$0$0$0$60.66M$22.47M$1.25M$0$0$0$133K$0$0$0$662K$0
Current Income Tax Payable$0$0$641K$1.29M$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$8.25M$21.93M$47.34M$36.12M$43.48M$0$0$6.27M$6.46M$4.18M$0$0$0$0$0
Other Current Liabilities$6.95M$13.3M$18.5M$4.04M$3.58M$24.69M$10.35M$8.53M$981K$369K$1.02M$0$0$0$0
Total Current Liabilities$36.38M$65.49M$81.99M$126.98M$99.54M$49.52M$21.32M$12.58M$11.04M$4.34M$2.35M$2.38M$1.64M$768K$219K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$40.63M$13.85M$14.99M$9.91M$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$12.6M$42.5M$20.07M$0$0$0$7.53M$7.19M$3.41M$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$26.61M$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$497K$2.8M$19.93M$12.51M$15.18M$8.07M$0$15K$0$0$0$0$0
Total Long-Term Liabilities$20.78M$37.6M$68.9M$53.09M$65.07M$30.38M$35.03M$17.98M$7.19M$3.42M$0$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0-$3.42M$0$0$0$0$0
Total Liabilities$57.16M$103.09M$150.89M$180.07M$164.6M$79.9M$56.35M$30.56M$18.23M$4.34M$2.35M$2.38M$1.64M$768K$219K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$28K$27K$27K$27K$26K$26K$15K$214K$212K$74K$74K$39K$39K$4K$4K
Retained Earnings-$514.59M-$448.81M-$367.87M-$338.14M-$347.49M-$143.82M-$71.67M-$44.87M-$23.09M-$95.62M-$71.02M-$51.57M-$18.73M-$8.19M-$6.61M
Comprehensive Income & Other$0$0$0$0$0$0$0$0-$3K-$6K-$111K-$60K-$30K-$22K-$15K
Other Stockholders' Equity$728.55M$689.76M$646.35M$608.43M$575.67M$540.34M$97.44M$58.3M$56.67M$142.77M$140.27M$71.47M$67.38M$7.62M$7.59M
Total Equity$213.99M$240.98M$278.51M$270.31M$228.21M$396.55M$25.79M$13.64M$33.79M$47.23M$69.33M$19.94M$48.69M-$567K$985K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$271.15M$344.07M$429.4M$450.39M$392.81M$476.46M$82.14M$44.2M$52.02M$51.57M$71.68M$22.32M$50.32M$201K$1.2M
Supplementary Data
Total Debt$25M$28.55M$30.22M$94.75M$69.15M$20.75M$20.67M$9.91M$0$133K$0$0$0$662K$0
Net Debt-$205.91M-$208.48M-$261.79M-$297.13M-$301.35M-$442.14M-$50.68M-$26.8M-$24.96M-$2.17M-$16.66M-$2.18M-$22.09M$565K-$55K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Operating Activities
Net Income-$65.78M-$80.94M-$29.73M$9.35M-$203.67M-$72.15M-$25.99M-$21.79M-$10.9M-$24.6M-$19.45M-$32.83M-$10.55M-$1.58M-$3.93M
Depreciation & Amortization$3.02M$3.54M$2.96M$1.53M$1.19M$882K$684K$582K$410K$294K$51K$31K$8K$7K$6K
Deferred Income Tax$0$0$0$0$0$0$25K$302K$0$0-$2.37M-$4.09M$1K$0$0
Stock-Based Compensation$25.41M$37.99M$34.65M$30.61M$28.91M$6.76M$1.98M$1.26M$2.17M$2.5M$2.37M$4.09M$1.54M$26K$1.55M
Changes in Working Capital:
  Accounts Receivable-$1.59M$28.09M-$29.3M$603K-$1.24M$54K$2.3M-$4M$3.15M-$1.56M-$1.08M$0$0$0$0
  Inventory$0$0$0$0$0$0$1.55M$2.11M-$306K$0$0$0$0$0$0
  Accounts Payable-$2.96M$1.92M-$2.24M-$3.11M-$769K$4.81M$3.15M$578K-$1.54M$471K-$248K$258K$24K-$113K$95K
  Other Working Capital-$34.65M-$50.81M$38.92M-$10.05M$34.64M$16.35M$8.97M$159K$6.05M$2.21M-$867K$130K$1.42M$12K-$86K
Total Working Capital Change-$39.2M-$20.81M$7.38M-$12.56M$32.63M$21.22M$15.98M-$1.16M$7.36M$2.68M-$1.11M$388K$1.44M-$101K$9K
Other Non-Cash Items$2.28M$471K-$33.36M$3.06M$5.9M$425K$873K$38K$498K-$110K$2.37M$4.09M$203K$62K$0
Net Cash from Operating-$74.27M-$59.75M-$18.1M$31.99M-$135.04M-$42.86M-$6.45M-$20.76M-$460K-$19.24M-$18.15M-$28.33M-$7.35M-$1.58M-$2.36M
Investing Activities
Capital Expenditures-$230K-$648K-$2.9M-$7.73M-$3.41M-$1.74M-$818K-$1.48M-$251K-$74K-$181K-$79K-$39K$0-$24K
Acquisitions$0$0$0$0$0$0$0$0$29K-$20.02M$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0-$6.59M$0-$17.37M-$33.5M$0-$28.01M$0-$517K
Sales of Investments$0$0$0$0$0$0$0$30.21M$10.58M$22.33M$0$8.49M$0$519K$0
Other Investing Activities$0$0$0$0$0$0$0$23.61M$29K$20.02M-$161K$8.49M-$28.01M$507K-$500K
Net Cash from Investing-$230K-$648K-$2.9M-$7.73M-$3.41M-$1.74M-$818K$22.13M$10.36M$4.88M-$33.84M$8.41M-$28.05M$1.03M-$1.04M
Financing Activities
Debt Repaid--$27.36M$5M-$46.6M--$4.95M-$9.87M-$5.65M--$1.89M----
Common Stock Issuance$13.38M$682K$609K$411K$515K$423.82M$21.28M$332K$477K$0$66.46M$0$57.25M$1K$2.17M
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$4.74M$2.67M$1.73M$902K$12.33M$15.68M$332K$1.35M$6K-$66.45M$0$29K$0$0
Net Cash from Financing$13.38M$5.42M-$24.09M-$2.86M$48.02M$436.14M$41.91M$10.2M$7M$6K$66.47M$0$57.4M$601K$2.62M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$61.12M-$54.98M-$45.09M$21.41M-$90.43M$391.54M$34.64M$11.58M$16.89M-$14.35M$14.48M-$19.92M$22M$42K-$782K
Supplementary Data
Operating Cash Flow-$74.27M-$59.75M-$18.1M$31.99M-$135.04M-$42.86M-$6.45M-$20.76M-$460K-$19.24M-$18.15M-$28.33M-$7.35M-$1.58M-$2.36M
Capital Expenditure-$230K-$648K-$2.9M-$7.73M-$3.41M-$1.74M-$818K-$1.48M-$251K-$74K-$181K-$79K-$39K$0-$24K
Free Cash Flow-$74.27M-$60.4M-$21M$24.27M-$138.45M-$44.6M-$7.26M-$22.24M-$711K-$19.32M-$18.33M-$28.41M-$7.39M-$1.58M-$2.38M
Cash at Beginning$293.91M$348.89M$393.98M$372.57M$463M$71.46M$36.82M$25.24M$8.35M$16.66M$2.18M$22.09M$97K$55K$837K
Cash at End$232.79M$293.91M$348.89M$393.98M$372.57M$463M$71.46M$36.82M$25.24M$2.3M$16.66M$2.18M$22.09M$97K$55K